Lumos Diagnostics Holdings Limited (LDXHF) Q4 2026 Earnings Call Transcript

SA Transcripts 161.29K Followers Follow Lumos Diagnostics Holdings Limited ( LDXHF ) Q4 2026 Earnings Call July 28, 2026 8:15 PM EDT Company Participants Douglas Ward - CEO, MD & Director Barrie Lambert - Chief Financial Officer Paul Kase - Senior Vice President of Commercial Operations Samuel Lanyon Conference Call Participants George Kopsiaftis - Investor Relations Department Pty Ltd Presentation George Kopsiaftis Investor Relations Department Pty Ltd All right. Good morning, everyone, and welcome to the Lumos Diagnostics Fourth Quarter '26 Investor Briefing. My name is George Kopsiaftis, and I'll be your moderator for this morning. Joining us from Lumos today, we have Doug Ward, Managing Director and CEO; Barrie Lambert, Chief Financial Officer; Paul Kase, the Chief Commercial Officer; and Sam Lanyon, the Chair of Lumos Diagnostics. As many of you would be aware, Doug is currently in Australia. He's meeting with a number of investors as part of a road show. And just as a reminder, Doug and Sam are presenting at an investor information session today in Melbourne, at 3:30 PM and on Monday in Sydney at 3:15 PM. Anyone that would still like to attend but hasn't RSVP'd, you can just refer to the ASX website for the details. So today, the team will be presenting the presentation that was lodged on Monday. The presentation should go for about 30 minutes, and then we'll open it up to Q&A. The plan is to be finished by 11:00, but we can run a little bit over, if needed. And at that stage, I'd like to hand it over to Doug. Douglas Ward CEO, MD & Director Excellent. Thank you very much, George. Terrific to be here. Sorry, I just squeezed Sam out of my view here, but that's okay. Thank you, everyone, for joining us today. Very excited to give this presentation and an update on our Q4 performance as well as a little bit of